Overview

Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single Application

Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
This eight-hour kinetic regression clinical study was conducted to assess the ability of MetroGel® 1% to deliver moisture to facial skin after a single application.
Phase:
Phase 4
Details
Lead Sponsor:
Galderma Laboratories, L.P.
Treatments:
Metronidazole